Drugs Made In America Acquisition Corp. Ordinary Shares
Financial ServicesNASDAQ:DMAA · NASDAQ Global Select
+$0.01 today
Vol 0.00M · Avg 0.11M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+4.27%
Period High
$10.62
Period Low
$10.18
Latest
$10.62
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Berto Acquisition Corp.
NASDAQ:TACO
$389.82M
Centurion Acquisition Corp.
NASDAQ:ALF
$387.41M
Berto Acquisition Corp. Unit
NASDAQ:TACOU
$374.49M
Titan Acquisition Corp.
NASDAQ:TACH
$358.80M
Oyster Enterprises II Acquisition Corp
NASDAQ:OYSE
$348.64M
SIM Acquisition Corp. I
NASDAQ:SIMA
$333.96M
Renatus Tactical Acquisition Corp I Class A Ordinary Shares
NASDAQ:RTAC
$323.77M
Live Oak Acquisition Corp. V Class A Ordinary Shares
NASDAQ:LOKV
$291.53M
Mountain Lake Acquisition Corp.
NASDAQ:MLAC
$96.70M
What is the latest DMAA filing?
The latest filing shown is SC 13G dated May 14, 2026.
How many recent filings does DMAA have?
Intrinsic Alpha currently shows 20 recent filings for DMAA.
Explore More
Continue the stock analysis
Jump to another research area for this company.